ADAPTIVE FUDICIALS FOR MULTI-MODAL RADIOTHERAPY
The present disclosure is related to an interstitial marker configured to be imaged when inserted into soft tissue of an organ, tumor or tumor bed within a subject's body, wherein the interstitial marker is optimized for multi-modality compatibility by maintaining necessary dimensions for visibility, trackability and material reduction in a beam path via customized pitch values to minimize proton beam perturbation.
1 . An interstitial marker configured to be imaged when inserted into soft tissue of a subject's body,
wherein the interstitial marker is optimized for multi-modality compatibility by maintaining necessary dimensions for visibility, trackability and material reduction in a beam path via customized pitch values to minimize proton beam perturbation, having a pitch value in a range of about 0.25 mm to about 1.5 mm, and
wherein the interstitial marker has a diameter of at least 0.50 mm.
2 . The interstitial marker of claim 1 , wherein the interstitial marker is a fiducial marker.
3 . The interstitial marker of claim 1 , wherein the interstitial marker has a diameter in a range of about 0.50 mm to about 0.75 mm
4 . The interstitial marker of claim 1 , wherein the interstitial marker has a mass in the range of 0.009 gram to 0.0266 gram.
5 . The interstitial marker of claim 1 , wherein the interstitial marker is configured to perform effectively across multiple treatment modalities.
6 . The interstitial marker of claim 1 , wherein the visibility and trackability of the interstitial marker is capable of evaluation under CT, MRI, IGRT, and CyberKnife® systems.
7 . The interstitial marker of claim 1 , wherein the interstitial marker is capable of providing assessments conducted for both photon and proton modalities.
8 . The interstitial marker of claim 1 , wherein the interstitial marker has a longitudinal length and rings made of a non-radioactive wire, the rings being held in spaced relation along the longitudinal length of the marker.
9 . The interstitial marker of claim 8 , wherein the longitudinal length of the interstitial marker is longer than an outer diameter of the rings.
10 . The interstitial marker of claim 9 , wherein the rings have an outer diameter of from 25 μm to 2500 μm.
11 . The interstitial marker of claim 8 , wherein a ratio of length of the interstitial marker to outer diameter of the rings is 10 or 25 more.
12 . The interstitial marker of claim 8 , wherein the a wire has a cross section length of from 10 μm to 2500 μm.
13 . The interstitial marker of claim 8 , wherein the interstitial marker is configured for insertion into soft tissue inside the subject's body and held by the soft tissue.
14 . The interstitial marker of claim 8 , wherein the longitudinal length of the interstitial marker, wire cross section length, outer diameter of the rings and ratio of longitudinal length of the interstitial marker to the outer diameter of the rings are effective for flexibility transverse to the longitudinal length of the marker and which flexibility is effective to permit the interstitial marker to be responsive to changes of shape of an organ, tumor or tumor bed and to follow movements of the organ, tumor, or tumor bed after insertion.
15 . The interstitial marker of claim 8 , wherein the rings are separated by a distance along the longitudinal length of the interstitial marker, and a ratio of wire cross section length to a separation distance of the rings is about 1:1.2±about 0.2.
16 . The interstitial marker of claim 15 , wherein the separation distance, the marker longitudinal length, the wire cross section length, the outer diameter of the rings, the ratio of longitudinal length to outer diameter of the rings is effective for providing lateral flexibility transverse to the longitudinal length of the marker.
17 . The interstitial marker of claim 8 , wherein the non-radioactive wire is flexible wire, wherein a portion of the flexible wire are formed in a helical coil, wherein the portion comprises sections of different pitch.
18 . The interstitial marker of claim 8 , wherein the non-radioactive wire has a circular cross section with a diameter of from 10 μm to 2500 μm, or a rectangular cross section with a length of from 10 μm to 500 μm.
19 . The interstitial marker of claim 1 , wherein portions of the interstitial marker are made of radiopaque material.
20 . The interstitial marker of claim 1 , wherein the interstitial marker is made of biocompatible material suitable for permanent implantation selected from at least one member of a group consisting of rhodium, platinum, iridium, tantalum, titanium, silver, gold, nickel, and stainless steel, or mixtures thereof.